UB Paderborn / Katalog / Suche / in CDI

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2017-09, Vol.318 (10), p.918

2017

Volltextzugriff (PDF)

Impact of Immediate Versus Delayed Axillary Node Dissection on Surgical Outcomes in Breast Cancer Patients With Positive Sentinel Nodes: Results From American College of Surgeons Oncology Group Trials Z0010 and Z0011

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3530-3535

2008

Volltextzugriff (PDF)

Image-Detected Breast Cancer: State-of-the-Art Diagnosis and Treatment

Journal of the American College of Surgeons, 2009, Vol.209 (4), p.504-520

2009

Volltextzugriff (PDF)

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

JAMA : the journal of the American Medical Association, 2011-02, Vol.305 (6), p.569

2011

Volltextzugriff (PDF)

Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer

JAMA : the journal of the American Medical Association, 2011-07, Vol.306 (4), p.385

2011

Volltextzugriff (PDF)

Use of Hydrogel Breast Biopsy Tissue Markers Reduces the Need for Wire Localization

Annals of surgical oncology, 2014-10, Vol.21 (10), p.3273-3277

2014

Volltextzugriff (PDF)

Increased Risk for Ipsilateral Breast Tumor Recurrence in Invasive Lobular Carcinoma after Accelerated Partial Breast Irradiation Brachytherapy

The oncologist (Dayton, Ohio), 2021-11, Vol.26 (11), p.e1931-e1938

2021

Volltextzugriff (PDF)

Molecular Analysis of Breast Sentinel Lymph Nodes

Surgical oncology clinics of North America, 2011-07, Vol.20 (3), p.467-485

2011

Volltextzugriff (PDF)

Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management

EBioMedicine, 2019-09, Vol.47, p.163-169

2019

Volltextzugriff (PDF)

Management of ductal carcinoma in situ with accelerated partial breast irradiation brachytherapy: Implications for guideline expansion

Brachytherapy, 2021-03, Vol.20 (2), p.345-352

2021

Volltextzugriff (PDF)

Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery

NEJM evidence, 2023-07, Vol.2 (7), p.EVIDoa2200333

2023

Volltextzugriff (PDF)

Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer

Annals of surgery, 2005-10, Vol.242 (4), p.593-602

2005

Volltextzugriff (PDF)

The clinically negative axilla: The dilemma of occult metastases in sentinel nodes

Bulletin of the American College of Surgeons, 2012-07, Vol.97 (7), p.64-65

2012

Volltextzugriff (PDF)

Adherence to the National Quality Forum (NQF) Breast Cancer Measures Within Cancer Clinical Trials: A Review From ACOSOG Z0010

Annals of surgical oncology, 2010-08, Vol.17 (8), p.1989-1994

2010

Volltextzugriff (PDF)

Abstract PS6-41: Mammaprint and blueprint as prognostic indicators for elderly patients with early stage breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS6-41-PS6-41

2021

Volltextzugriff (PDF)

Abstract PS15-18: Clinical utility of genomic testing for early stage breast cancer patients treated with APBI brachytherapy

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS15-18-PS15-18

2021

Volltextzugriff (PDF)

Abstract CT220: Expansion into multiple institutions for training in the use of the LUM Imaging System for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT220-CT220

2019

Volltextzugriff (PDF)

Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer managementResearch in context

EBioMedicine, 2019-09, Vol.47, p.163-169

2019

Volltextzugriff (PDF)

Giant cellular blue nevus of the anterior chest wall mimicking metastatic melanoma to the breast: A case report

Journal of surgical oncology, 2000-08, Vol.74 (4), p.278-281

2000

Volltextzugriff (PDF)

Sentinel node skills verification and surgeon performance : Data from a multicenter clinical trial for early-stage breast cancer. Discussion

Annals of surgery, 2005, Vol.242 (4), p.593-602

2005

Volltextzugriff (PDF)

Special report: Consensus conference III. Image-detected breast cancer: state-of-the-art diagnosis and treatment

Journal of the American College of Surgeons, 2009-10, Vol.209 (4), p.504-520

2009

Volltextzugriff (PDF)

Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial

Annals of surgery, 2016-09, Vol.264 (3), p.413-420

2016

Volltextzugriff (PDF)

Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial

Annals of surgery, 2010-09, Vol.252 (3), p.426-433

2010

Volltextzugriff (PDF)

Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors

The American journal of surgery, 2007-10, Vol.194 (4), p.426-432

2007

Volltextzugriff (PDF)

Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancer

Surgical oncology, 2022-12, Vol.45, p.101885-101885, Article 101885

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial

Impact of Immediate Versus Delayed Axillary Node Dissection on Surgical Outcomes in Breast Cancer Patients With Positive Sentinel Nodes: Results From American College of Surgeons Oncology Group Trials Z0010 and Z0011

Image-Detected Breast Cancer: State-of-the-Art Diagnosis and Treatment

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer

Use of Hydrogel Breast Biopsy Tissue Markers Reduces the Need for Wire Localization

Increased Risk for Ipsilateral Breast Tumor Recurrence in Invasive Lobular Carcinoma after Accelerated Partial Breast Irradiation Brachytherapy

Molecular Analysis of Breast Sentinel Lymph Nodes

Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management

Management of ductal carcinoma in situ with accelerated partial breast irradiation brachytherapy: Implications for guideline expansion

Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery

Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer

The clinically negative axilla: The dilemma of occult metastases in sentinel nodes

Adherence to the National Quality Forum (NQF) Breast Cancer Measures Within Cancer Clinical Trials: A Review From ACOSOG Z0010

Abstract PS6-41: Mammaprint and blueprint as prognostic indicators for elderly patients with early stage breast cancer

Abstract PS15-18: Clinical utility of genomic testing for early stage breast cancer patients treated with APBI brachytherapy

Abstract CT220: Expansion into multiple institutions for training in the use of the LUM Imaging System for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer

Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer managementResearch in context

Giant cellular blue nevus of the anterior chest wall mimicking metastatic melanoma to the breast: A case report

Sentinel node skills verification and surgeon performance : Data from a multicenter clinical trial for early-stage breast cancer. Discussion

Special report: Consensus conference III. Image-detected breast cancer: state-of-the-art diagnosis and treatment

Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial

Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial

Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors

Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancer

Suchergebnisse filtern